Solid-phase synthesis of symmetrical 3,6-bispeptide-acridone conjugates

Organic Letters

Volumn 4, Issue 15, 2002, Pages 2509-2512

  Ladame, Sylvain ^a   Harrison, R John ^b   Neidle, Stephen ^b   Balasubramanian, Shankar ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ACRIDONE; ANTINEOPLASTIC AGENT; DIPEPTIDE; DNA; GUANINE QUADRUPLEX; LIGAND;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; METHODOLOGY; MOLECULAR MIMICRY; PEPTIDE LIBRARY; SYNTHESIS; TELOMERE;

ACRIDINES; ANTINEOPLASTIC AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DIPEPTIDES; DNA; DRUG DESIGN; G-QUADRUPLEXES; LIGANDS; MOLECULAR MIMICRY; PEPTIDE LIBRARY; TELOMERE;

EID: 0038820705     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol026130p     Document Type: Article

References (28)

1. (a) Zahler, A. M.; Williamson, J. R.; Cech, T. R.; Prescott, D. M. Nature (London) 1991, 350, 718-720.
2. (b) Kelland, L. R. Anticancer Drugs 2000, 11, 503-513.
3. (c) Kerwin, S. M. Curr. Pharm. Des. 2000, 6, 441-78.
4. (a) Sun D.; Thompson, B.; Cathers, B. E.; Salazar, M.; Kerwin, S. M.; Trent, J. O.; Jenkins, T. C.; Neidle, S.; Hurley, L. H. J. Med. Chem. 1997, 40, 2113-2116.
5. (b) Mergny, J. L.; Helene, C. Nature Med. 1998, 4, 1366-1367.
6. (c) Mergny, J. L.; Mailliet, P.; Lavelle, F.; Riou, J. F.; Laoui, A.; Helene, C. Anticancer Drug Des. 1999, 14, 327-339.
7. (a) Han, H.; Bennett, R. J.; Hurley, L. H. Biochemistry 2000, 39, 9311-9316.
8. (b) Li, J.-L.; Harrison, R. J.; Reszka, A. P.; Brosh, R. M.; Bohr, V. A.; Neidle, S.; Hickson, I. D. Biochemistry 2001, 40, 15194-15202.
9. Rangan, A.; Fedoroff, O. Y.; Hurley, L. H. J. Biol. Chem. 2001, 276, 4640-4646.
10. Mergny, J. L.; Riou, J. F.; Mailliet, P.; Teulade-Fichou, M. P.; Gilson E. Nucleic Acids Res. 2002, 30, 839-865.
11. Han, H.; Langley, D. R.; Rangan, A.; Hurley, L. H. J. Am. Chem. Soc. 2001, 123, 6485-6495.
12. Fedoroff, O. Y.; Salazar, M.; Han, H.; Chemeris, V. V.; Kerwin, S. M.; Hurley L. H. Biochemistry 1998, 37, 12367-12374.
13. Perry P. J.; Reszka, A. P.; Wood, A. A.; Read, M. A.; Gowan, S. M.; Dosahjh, H. S.; Trent, J. O.; Jenkins, T. C.; Kelland, L. R.; Neidle, S. J. Med. Chem. 1998, 41, 4873-4884.
14. Harrison, R. J.; Gowan, S. M.; Kelland, L. R.; Neidle, S. Bioorg. Med. Chem. Lett. 1999, 9, 2463-2465.
15. Read, M.; Harrison, R. J.; Romagnoli, B.; Tanious F. A.; Gowan, S. H.; Reszka, A. P.; Wilson, W. D.; Kelland, L. R.; Neidle, S. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 4844-4849.
16. Gowan, S. M.; Harrison, R. J.; Patterson, L.; Valenti, M.; Read, M. A.; Neidle, S.; Kelland, L. R. Molec. Pharmacol. 2002, 61, 1154-1162.
17. Read, M. A.; Neidle, S. Biochemistry 2000, 39, 13422-13432.
18. Haider, S.; Parkinson, G. N.; Neidle, S. Manuscript in preparation.
19. Park, H. S.; Lin, Q.; Hamilton A. D. J. Am. Chem. Soc. 1999, 121, 8-13.
20. Burgess, K. Acc. Chem. Res. 2001, 34, 826-835.
21. Balasubramanian, S.; Schouten J. A. Unpublished results.
22. Carlson, C. B.; Beal, P. A. Org. Lett. 2000, 2, 1465-1468.
23. Carlson, C. B.; Beal, P. A. Bioorg. Med. Chem. Lett. 2000, 10, 1979-1982.
24. For early examples of site - site interactions, see: Rapoport, H.; Crowley, J. I. Acc. Chem. Res. 1976, 9, 135-144.
25. Yan, B.; Sun, Q. J. Org. Chem. 1998, 63, 55-58.
26. Brouwer, A. J.; van der Linden, H. J.; Liskamp, R. M. J. J. Org. Chem. 2000, 65, 1750-1757.
27. (a) Blackwell, H. E.; Clemons, P. A.; Schreiber, S. L. Org. Lett. 2001, 3, 1185-1188.
28. (b)Tang, Q.; Wareing, J. R. Tetrahedron Lett. 2001, 42, 1399-1401.